Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Equity (2016 - 2025)

Medifast's Return on Equity history spans 15 years, with the latest figure at 0.09% for Q4 2025.

  • For Q4 2025, Return on Equity fell 10.0% year-over-year to 0.09%; the TTM value through Dec 2025 reached 0.09%, down 10.0%, while the annual FY2025 figure was 0.09%, 10.0% down from the prior year.
  • Return on Equity reached 0.09% in Q4 2025 per MED's latest filing, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.08% in Q3 2022 to a low of 0.09% in Q4 2025.
  • Average Return on Equity over 5 years is 0.5%, with a median of 0.69% recorded in 2023.
  • Peak YoY movement for Return on Equity: rose 27bps in 2022, then crashed -60bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.82% in 2021, then rose by 14bps to 0.94% in 2022, then crashed by -46bps to 0.5% in 2023, then plummeted by -98bps to 0.01% in 2024, then plummeted by -1012bps to 0.09% in 2025.
  • Per Business Quant, the three most recent readings for MED's Return on Equity are 0.09% (Q4 2025), 0.0% (Q3 2025), and 0.02% (Q2 2025).